Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
1.
Article de Anglais | WPRIM | ID: wpr-719283

RÉSUMÉ

BACKGROUND/AIMS: Fecal calprotectin (FC) is known to correlate with disease activity and can be used as a predictor for relapse or treatment response in inflammatory bowel disease (IBD). We evaluated the usefulness of FC as a biomarker for disease activity in patients with IBD using both enzyme-linked immunosorbent assay (ELISA) and a quantitative point-of-care test (QPOCT). METHODS: Fecal samples and medical records were collected from consecutive patients with IBD. FC levels were measured by both ELISA and QPOCT and patient medical records were reviewed for clinical, laboratory, and endoscopic data. RESULTS: Ninety-three patients with IBD were enrolled, 55 with ulcerative colitis (UC) and 38 with Crohn's disease (CD). The mean FC-ELISA levels were 906.3 ± 1,484.9 μg/g in UC and 1,054.1 ± 1,252.5 μg/g in CD. There was a strong correlation between FC-ELISA level and clinical activity indices (p < 0.05). FC-ELISA level was significantly lower in patients with mucosal healing (MH) compared to those without MH in UC (85.5 ± 55.6 μg/g vs. 1,503.7 ± 2,129.9 μg/g, p = 0.005). The results from the QPOCT corresponded well to those from ELISA. A cutoff value of 201.3 μg/g for FC-ELISA and 150.5 μg/g for FC-QPOCT predicted endoscopic inflammation (Mayo endoscopic subscore ≥ 1) in UC with a sensitivity of 81.8% and 85.8%, respectively, and a specificity of 100% for both. CONCLUSIONS: FC was strongly associated with disease activity indices, serologic markers, and endoscopic activity in patients with IBD. QPOCT can be used more conveniently than ELISA to assess FC in clinical practice.


Sujet(s)
Humains , Rectocolite hémorragique , Maladie de Crohn , Test ELISA , Inflammation , Maladies inflammatoires intestinales , Complexe antigénique L1 leucocytaire , Dossiers médicaux , Systèmes automatisés lit malade , Récidive , Sensibilité et spécificité
2.
Article de Coréen | WPRIM | ID: wpr-103645

RÉSUMÉ

Plasma cell myelomas generally manifest as bone or soft-tissue tumors with variable mass effects, pain, and infiltrative behavior. Extramedullary involvement occurs most commonly in the spleen, liver, lymph nodes, and kidneys, but intracranial involvement in plasma cell myeloma is a rare extramedullary manifestation. These authors recently encountered a case of intracranial involvement of plasma cell myeloma. A 69-year-old man was hospitalized for headache and mental changes. Brain CT showed subdural hemorrhage caused by plasma cell myeloma. Plasma cell myeloma with intracranial involvement has poor prognosis, and the patient in this case died from acute complications, such as subdural hemorrhage. Based on this case report, it is suggested that more effective treatment regimens of plasma cell myeloma with intracranial involvement be developed. Moreover, a screening method and decision on the appropriate time for intracranial involvement are needed for plasma cell myeloma patients.


Sujet(s)
Sujet âgé , Humains , Encéphale , Tumeurs du cerveau , Céphalée , Hématome subdural , Rein , Foie , Noeuds lymphatiques , Dépistage de masse , Myélome multiple , Plasma sanguin , Plasmocytes , Pronostic , Rate
3.
Immune Network ; : 126-128, 2012.
Article de Anglais | WPRIM | ID: wpr-145818

RÉSUMÉ

We report on a case of severe hepatotoxicity in a 52-year-old male with multiple myeloma (MM) who had received bortezomib therapy. At patient presentation, liver enzymes were normal, but started to markedly increase 3 days after the patient's second dose of bortezomib was administered, when free kappa light chains were noticeably reduced in the serum. After discontinuation of bortezomib, liver enzymes recovered gradually to baseline. Then, the patient was started on a thalidomide-containing regimen, which he was able to tolerate well. The patient achieved complete remission prior to autologous stem cell transplantation (ASCT). The patient underwent ASCT without occurrence of further liver toxicity.


Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Acides boroniques , Bortézomib , Lésions hépatiques dues aux substances , Lumière , Foie , Myélome multiple , Pyrazines , Transplantation de cellules souches
4.
Article de Anglais | WPRIM | ID: wpr-221404

RÉSUMÉ

Eosinophilic gastroenteritis is defined as primary eosinophilic infiltration of the gastrointestinal tract. Endoscopic findings of this disease entity are non-specific, and huge gastric ulceration as initial presentation is extremely rare. We experienced a case of eosinophilic gastroenteritis presenting with abdominal pain in a 38 year-old-woman. Deep and huge ulceration in gastric antrum and body looked like advanced gastric cancer. Surgical resection was performed and histopathological examination showed dense infiltration of eosinophil without malignant cells. 5 years after surgery, diffuse abdominal pain and generalized edema developed and computed tomography showed entire wall thickening of the gastrointestinal tract. Random mucosal biopsy of the remnant stomach and terminal ileum showed mucosal eosinophilic infiltrations. She was treated with steroids and azathioprine but experienced frequent relapses and was dependent on steroids to maintain remissions. After 3 years, she died from infective endocarditis due to the prolonged use of immunosuppressive agents.


Sujet(s)
Douleur abdominale , Azathioprine , Biopsie , Oedème , Endocardite , Entérite , Éosinophilie , Granulocytes éosinophiles , Moignon gastrique , Gastrite , Gastroentérite , Tube digestif , Iléum , Immunosuppresseurs , Antre pylorique , Récidive , Stéroïdes , Tumeurs de l'estomac , Ulcère gastrique , Ulcère
5.
Article de Anglais | WPRIM | ID: wpr-10266

RÉSUMÉ

A 47-year old man visited our hospital because of purulent sputum for 3 months. Chest X-ray showed destruction of both the upper lungs, and bronchoscopy revealed inflammatory change with whitish plaque on the left main bronchus through upper division of the left upper lobe. Tracheobronchial aspergillosis (TBA) was finally diagnosed as a result of histologic and microbiologic examination. However, he went abroad without medication before the diagnosis was made and visited again 10 months later. Follow-up bronchoscopy showed complete regression of the previously noted endobronchial lesion. We describe this case to consider the role of antifungal treatment in immunocompetent hosts, as well as to discuss a rare condition; TBA resolved spontaneously.


Sujet(s)
Aspergillose , Bronches , Maladies des bronches , Bronchoscopie , Études de suivi , Immunocompétence , Poumon , Expectoration , Thorax
6.
Article de Coréen | WPRIM | ID: wpr-214182

RÉSUMÉ

Photodynamic therapy (PDT) is a non-invasive treatment for cancer that works through a photochemical effect after the administration of a photosensitizer. At first, PDT had been used for the relief of obstructive symptoms caused by exophytic esophageal cancer or for control of tumor overgrowth. Recently, several investigators have reported the use of PDT in early esophageal cancer with encouraging results. This report describes a case of a 52-year-old man with early esophageal cancer, who had a long history of liver cirrhosis with esophageal varix. The patient was treated successfully with PDT using porfimer sodium as the photosensitizer. PDT is an alternative to surgical treatment of early esophageal cancer, especially in patients with liver cirrhosis.


Sujet(s)
Humains , Adulte d'âge moyen , Éther de dihématoporphyrine , Varices oesophagiennes et gastriques , Tumeurs de l'oesophage , Foie , Cirrhose du foie , Photothérapie dynamique , Personnel de recherche , Triazènes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE